Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation
Objective: To determine if the biologically active or bioavailable inhibin B (bio-inhB) correlated with the oocyte yield in controlled ovarian stimulation (COS). Design: Cross-sectional study. Setting: Academic center. Patient(s): Women undergoing oocyte cryopreservation. Intervention(s): None. Main...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | F&S Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666334121000313 |
id |
doaj-df1c2a912e03437ea09676c88f099cb2 |
---|---|
record_format |
Article |
spelling |
doaj-df1c2a912e03437ea09676c88f099cb22021-06-19T04:56:24ZengElsevierF&S Reports2666-33412021-06-0122189194Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulationRachel B. Danis, M.D., M.S.0Intira Sriprasert, Ph.D.1Jacqueline R. Ho, M.D., M.S.2Lynda K. McGinnis, Ph.D.3Ajay Kumar, Ph.D.4Frank Z. Stanczyk, Ph.D.5Departments of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California; Reprint requests: Rachel B. Danis, M.D., M.S., Departments of Obstetrics and Gynecology, University of Southern California, 2020 Zonal Avenue IRD 534, Los Angeles, California 90033.Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CaliforniaDepartments of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CaliforniaDepartments of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CaliforniaAnsh Labs, Webster, TexasDepartments of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California; Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CaliforniaObjective: To determine if the biologically active or bioavailable inhibin B (bio-inhB) correlated with the oocyte yield in controlled ovarian stimulation (COS). Design: Cross-sectional study. Setting: Academic center. Patient(s): Women undergoing oocyte cryopreservation. Intervention(s): None. Main Outcome Measure(s): Serum of women were sampled to measure bio-inhB at three points: baseline (“start”); middle (“mid”); and end of COS. A validated, highly specific enzyme-linked immunosorbent assay (Ansh Labs, Webster, TX) measured bio-inhB. The Spearman tests analyzed correlations between bio-inhB and other ovarian reserve markers, including age, follicle-stimulating hormone (FSH), antral follicle count (AFC), and antimüllerian hormone (AMH), and correlations between these markers and oocyte yield. Result(s): A total of 144 women were included. Bioavailable inhibin B at the mid and end of COS, plus its delta, were strongly correlated with other ovarian reserve markers. As the bio-inhB concentration increased, the AFC and AMH levels also increased, whereas the FSH concentration and age decreased. Bioavailable inhibin B values, except at the start of COS, were more strongly correlated with oocyte yield than the FSH concentration (r = 0.72–0.82 vs. r = −0.44) and correlated similarly to the AFC and AMH concentration (r = 0.79 and 0.81, respectively). These correlations strengthened in those with diminished ovarian reserve, specifically age ≥35 years or AMH concentration <2 ng/mL (r = 0.71–0.86 vs. r = 0.49–0.67). Conclusion(s): Predicting COS outcome is imperfect. When using a highly specific enzyme-linked immunosorbent assay, bio-inhB correlated with the oocyte yield similar to or more strongly than traditionally used ovarian reserve markers. These correlations strengthened in cases of diminished ovarian reserve. Bioavailable inhibin B provides physicians with an additional clinical tool for estimating COS outcome.http://www.sciencedirect.com/science/article/pii/S2666334121000313Inhibin Bovarian reservecontrolled ovarian stimulationoocyte yield |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rachel B. Danis, M.D., M.S. Intira Sriprasert, Ph.D. Jacqueline R. Ho, M.D., M.S. Lynda K. McGinnis, Ph.D. Ajay Kumar, Ph.D. Frank Z. Stanczyk, Ph.D. |
spellingShingle |
Rachel B. Danis, M.D., M.S. Intira Sriprasert, Ph.D. Jacqueline R. Ho, M.D., M.S. Lynda K. McGinnis, Ph.D. Ajay Kumar, Ph.D. Frank Z. Stanczyk, Ph.D. Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation F&S Reports Inhibin B ovarian reserve controlled ovarian stimulation oocyte yield |
author_facet |
Rachel B. Danis, M.D., M.S. Intira Sriprasert, Ph.D. Jacqueline R. Ho, M.D., M.S. Lynda K. McGinnis, Ph.D. Ajay Kumar, Ph.D. Frank Z. Stanczyk, Ph.D. |
author_sort |
Rachel B. Danis, M.D., M.S. |
title |
Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation |
title_short |
Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation |
title_full |
Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation |
title_fullStr |
Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation |
title_full_unstemmed |
Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation |
title_sort |
association of bioavailable inhibin b and oocyte yield in controlled ovarian stimulation |
publisher |
Elsevier |
series |
F&S Reports |
issn |
2666-3341 |
publishDate |
2021-06-01 |
description |
Objective: To determine if the biologically active or bioavailable inhibin B (bio-inhB) correlated with the oocyte yield in controlled ovarian stimulation (COS). Design: Cross-sectional study. Setting: Academic center. Patient(s): Women undergoing oocyte cryopreservation. Intervention(s): None. Main Outcome Measure(s): Serum of women were sampled to measure bio-inhB at three points: baseline (“start”); middle (“mid”); and end of COS. A validated, highly specific enzyme-linked immunosorbent assay (Ansh Labs, Webster, TX) measured bio-inhB. The Spearman tests analyzed correlations between bio-inhB and other ovarian reserve markers, including age, follicle-stimulating hormone (FSH), antral follicle count (AFC), and antimüllerian hormone (AMH), and correlations between these markers and oocyte yield. Result(s): A total of 144 women were included. Bioavailable inhibin B at the mid and end of COS, plus its delta, were strongly correlated with other ovarian reserve markers. As the bio-inhB concentration increased, the AFC and AMH levels also increased, whereas the FSH concentration and age decreased. Bioavailable inhibin B values, except at the start of COS, were more strongly correlated with oocyte yield than the FSH concentration (r = 0.72–0.82 vs. r = −0.44) and correlated similarly to the AFC and AMH concentration (r = 0.79 and 0.81, respectively). These correlations strengthened in those with diminished ovarian reserve, specifically age ≥35 years or AMH concentration <2 ng/mL (r = 0.71–0.86 vs. r = 0.49–0.67). Conclusion(s): Predicting COS outcome is imperfect. When using a highly specific enzyme-linked immunosorbent assay, bio-inhB correlated with the oocyte yield similar to or more strongly than traditionally used ovarian reserve markers. These correlations strengthened in cases of diminished ovarian reserve. Bioavailable inhibin B provides physicians with an additional clinical tool for estimating COS outcome. |
topic |
Inhibin B ovarian reserve controlled ovarian stimulation oocyte yield |
url |
http://www.sciencedirect.com/science/article/pii/S2666334121000313 |
work_keys_str_mv |
AT rachelbdanismdms associationofbioavailableinhibinbandoocyteyieldincontrolledovarianstimulation AT intirasriprasertphd associationofbioavailableinhibinbandoocyteyieldincontrolledovarianstimulation AT jacquelinerhomdms associationofbioavailableinhibinbandoocyteyieldincontrolledovarianstimulation AT lyndakmcginnisphd associationofbioavailableinhibinbandoocyteyieldincontrolledovarianstimulation AT ajaykumarphd associationofbioavailableinhibinbandoocyteyieldincontrolledovarianstimulation AT frankzstanczykphd associationofbioavailableinhibinbandoocyteyieldincontrolledovarianstimulation |
_version_ |
1721371673985286144 |